These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 15270590)
1. Modifications of cellular autofluorescence emission spectra under oxidative stress induced by 1 alpha,25dihydroxyvitamin D(3) and its analog EB1089. Bondza-Kibangou P; Millot C; Dufer J; Millot JM Technol Cancer Res Treat; 2004 Aug; 3(4):383-91. PubMed ID: 15270590 [TBL] [Abstract][Full Text] [Related]
2. Antioxidants and doxorubicin supplementation to modulate CD14 expression and oxidative stress induced by vitamin D3 and seocalcitol in HL60 cells. Bondza-Kibangou P; Millot C; El Khoury V; Millot JM Oncol Rep; 2007 Dec; 18(6):1513-9. PubMed ID: 17982638 [TBL] [Abstract][Full Text] [Related]
3. Microspectrofluorometry of autofluorescence emission from human leukemic living cells under oxidative stress. Bondza-Kibangou P; Millot C; Dufer J; Millot JM Biol Cell; 2001 Nov; 93(5):273-80. PubMed ID: 11770840 [TBL] [Abstract][Full Text] [Related]
4. Effect of a vitamin D3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts. Lee YY; Kim ES; Seol JG; Kim BK; Binderup L; Elstner E; Park DJ; Koeffler HP Leukemia; 1996 Nov; 10(11):1751-7. PubMed ID: 8892678 [TBL] [Abstract][Full Text] [Related]
5. Effect of a novel vitamin D3 analog, EB1089, on G1 cell cycle regulatory proteins in HL-60 cells. Seol JG; Park WH; Kim ES; Jung CW; Binderup L; Koeffler HP; Kim BK; Lee YY Int J Oncol; 2000 Feb; 16(2):315-20. PubMed ID: 10639575 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways. Liu W; Asa SL; Fantus IG; Walfish PG; Ezzat S Am J Pathol; 2002 Feb; 160(2):511-9. PubMed ID: 11839571 [TBL] [Abstract][Full Text] [Related]
7. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity. Quack M; Clarin A; Binderup E; Björkling F; Hansen CM; Carlberg C J Cell Biochem; 1998 Dec; 71(3):340-50. PubMed ID: 9831071 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of the vitamin D3 analogue EB1089 alters receptor complex formation and reduces promoter selectivity. Quack M; Mørk Hansen C; Binderup E; Kissmeyer AM; Carlberg C Br J Pharmacol; 1998 Oct; 125(4):607-14. PubMed ID: 9831892 [TBL] [Abstract][Full Text] [Related]
9. 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Heine G; Anton K; Henz BM; Worm M Eur J Immunol; 2002 Dec; 32(12):3395-404. PubMed ID: 12432570 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302 [TBL] [Abstract][Full Text] [Related]
11. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro. James SY; Mercer E; Brady M; Binderup L; Colston KW Br J Pharmacol; 1998 Nov; 125(5):953-62. PubMed ID: 9846632 [TBL] [Abstract][Full Text] [Related]
12. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089. Zhang X; Jiang F; Li P; Li C; Ma Q; Nicosia SV; Bai W Clin Cancer Res; 2005 Jan; 11(1):323-8. PubMed ID: 15671562 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study. Ghous Z; Akhter J; Pourgholami MH; Morris DL Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661 [TBL] [Abstract][Full Text] [Related]
15. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Nayeri S; Danielsson C; Kahlen JP; Schräder M; Mathiasen IS; Binderup L; Carlberg C Oncogene; 1995 Nov; 11(9):1853-8. PubMed ID: 7478614 [TBL] [Abstract][Full Text] [Related]
16. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089. VanWeelden K; Flanagan L; Binderup L; Tenniswood M; Welsh J Endocrinology; 1998 Apr; 139(4):2102-10. PubMed ID: 9528999 [TBL] [Abstract][Full Text] [Related]
17. Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues. Danielsson C; Fehsel K; Polly P; Carlberg C Cell Death Differ; 1998 Nov; 5(11):946-52. PubMed ID: 9846181 [TBL] [Abstract][Full Text] [Related]
18. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells. Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613 [TBL] [Abstract][Full Text] [Related]
19. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo. Haq M; Kremer R; Goltzman D; Rabbani SA J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854 [TBL] [Abstract][Full Text] [Related]
20. The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells. Park WH; Seol JG; Kim ES; Binderup L; Koeffler HP; Kim BK; Lee YY Int J Oncol; 2002 Mar; 20(3):533-42. PubMed ID: 11836565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]